OmniAb, Inc. (OABI)
NASDAQ · Services · Services-commercial physical & biological research
$4.71−$0.0780 (−1.63%) on the dayAs of the close; data may be delayed.
OABI price, last 12 months
Key stats
- Previous close
- $4.79
- Open
- $4.80
- Day range
- $4.57 – $4.85
- 52-week range
- $1.30 – $5.43
- Volume
- 678.3K
- Avg volume (20 days)
- 1.5M
- Market cap
- $670.2M
Performance
1W+5.4%
1M−2.0%
3M+87.0%
6M+198.2%
YTD+154.7%
1Y+198.2%
vs S&P 500, 1Y+181.5 pts
Technicals and fundamentals
About OmniAb, Inc.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
- Sector
- Services
- Industry
- Services-commercial physical & biological research
- Listed on
- NASDAQ
- Market cap
- $670.2M